高级检索
当前位置: 首页 > 详情页

Neutrophil Extracellular Traps Mediate Acute Liver Failure in Regulation of miR-223/Neutrophil Elastase Signaling in Mice.

文献详情

资源类型:
Pubmed体系:
机构: [1]Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong PharmaceuticalUniversity, Guangzhou, China [2]Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, GuangdongPharmaceutical University, Guangzhou, China [3]Guangdong TCM Key Laboratory for Metabolic Diseases, GuangdongPharmaceutical University, Guangzhou, China [4]Key Laboratory of Metabolic Phenotyping in Model Animals, GuangdongPharmaceutical University, Guangzhou, China [5]School of Chinese Medicine, Guangdong Pharmaceutical University,Guangzhou, China [6]Department of Endocrinology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China [7]Shenzhen Longhua Maternity and Child Healthcare Hospital, Shenzhen, China [8]Guangdong Province Key Laboratory forBiotechnology Drug Candidates, Institute of Basic Medical Sciences, Department of Biotechnology, School of Life Sciencesand Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, China [9]State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, Hong Kong, China
出处:

关键词: Hepatocellular Injury NET Inhibitors Neutrophil Degranulation

摘要:
Marked enhancement of neutrophil infiltration in the liver is a hallmark of acute liver failure (ALF), a severe life-threatening disease with varying etiologies. However, the mechanisms and pathophysiological role corresponding to hepatic neutrophil infiltration during ALF development remain poorly characterized.Experimental ALF was induced in 10-week-old male microRNA-223 (miR-223) knockout (KO) mice, neutrophil elastase (NE) KO mice, and wild-type controls by intraperitoneal injection of galactosamine hydrochloride and lipopolysaccharide. Age-matched mice were injected with phosphate-buffered saline and served as vehicle controls.Mouse liver with ALF showed evident formation of neutrophil extracellular traps (NETs), which were enhanced markedly in miR-223 KO mice. The blockade of NETs by pharmacologic inhibitor GSK484 significantly attenuated neutrophil infiltration and massive necrosis in mouse liver with ALF. ALF-related hepatocellular damage and mortality in miR-223 KO mice were aggravated significantly and accompanied by potentiated neutrophil infiltration in the liver when compared with wild-type controls. Transcriptomic analyses showed that miR-223 deficiency in bone marrow predominantly caused the enrichment of pathways involved in neutrophil degranulation. Likewise, ALF-induced hepatic NE enrichment was potentiated in miR-223 KO mice. Genetic ablation of NE blunted the formation of NETs in parallel with significant attenuation of ALF in mice. Pharmaceutically, pretreatment with the NE inhibitor sivelestat protected mice against ALF.The present study showed the miR-223/NE axis as a key modulator of NETs, thereby exacerbating oxidative stress and neutrophilic inflammation to potentiate hepatocellular damage and liver necrosis in ALF development, and offering potential targets against ALF.Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 1 区 医学
小类 | 2 区 胃肠肝病学
最新[2025]版:
大类 | 1 区 医学
小类 | 2 区 胃肠肝病学
第一作者:
第一作者机构: [1]Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong PharmaceuticalUniversity, Guangzhou, China [2]Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, GuangdongPharmaceutical University, Guangzhou, China [3]Guangdong TCM Key Laboratory for Metabolic Diseases, GuangdongPharmaceutical University, Guangzhou, China [4]Key Laboratory of Metabolic Phenotyping in Model Animals, GuangdongPharmaceutical University, Guangzhou, China [*1]Laboratory 406, 4th Floor, Science and Technology Building, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega, 280 Waihuan East Road, Guangzhou 510006, China.
共同第一作者:
通讯作者:
通讯机构: [1]Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangdong PharmaceuticalUniversity, Guangzhou, China [2]Key Laboratory of Glucolipid Metabolic Diseases of the Ministry of Education, GuangdongPharmaceutical University, Guangzhou, China [3]Guangdong TCM Key Laboratory for Metabolic Diseases, GuangdongPharmaceutical University, Guangzhou, China [4]Key Laboratory of Metabolic Phenotyping in Model Animals, GuangdongPharmaceutical University, Guangzhou, China [*1]Laboratory 406, 4th Floor, Science and Technology Building, Guangdong Pharmaceutical University, Guangzhou Higher Education Mega, 280 Waihuan East Road, Guangzhou 510006, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2022 今日访问量:0 总访问量:648 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号